| 000 | 01387 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516143350.0 | ||
| 264 | 0 | _c20130417 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.1237998 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMignot, Emmanuel | |
| 245 | 0 | 0 |
_aPhysiology. The perfect hypnotic? _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cApr 2013 |
||
| 300 |
_a36-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBenzodiazepines _xchemistry |
| 650 | 0 | 4 |
_aChlordiazepoxide _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xchemistry |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeuropeptides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xchemistry |
| 650 | 0 | 4 | _aOrexin Receptors |
| 650 | 0 | 4 | _aOrexins |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Neuropeptide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aSleep, REM _xdrug effects |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 340 _gno. 6128 _gp. 36-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.1237998 _zAvailable from publisher's website |
| 999 |
_c22643614 _d22643614 |
||